| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myelodysplastic Syndromes | 63 | 2023 | 1352 | 11.020 |
Why?
|
| Leukemia, Myeloid, Acute | 61 | 2023 | 3523 | 7.310 |
Why?
|
| Myeloproliferative Disorders | 34 | 2023 | 606 | 6.560 |
Why?
|
| Bone Marrow | 60 | 2023 | 2948 | 6.120 |
Why?
|
| Leukemia, Erythroblastic, Acute | 10 | 2018 | 189 | 2.590 |
Why?
|
| Chromosome Aberrations | 23 | 2023 | 1813 | 2.230 |
Why?
|
| Hodgkin Disease | 12 | 2022 | 1415 | 1.850 |
Why?
|
| Leukemia, Myeloid | 7 | 2019 | 707 | 1.820 |
Why?
|
| Mutation | 60 | 2023 | 29786 | 1.520 |
Why?
|
| Hematologic Neoplasms | 16 | 2023 | 1832 | 1.510 |
Why?
|
| World Health Organization | 16 | 2022 | 1318 | 1.460 |
Why?
|
| Myelodysplastic-Myeloproliferative Diseases | 4 | 2022 | 13 | 1.320 |
Why?
|
| Leukemia, Neutrophilic, Chronic | 2 | 2019 | 12 | 1.300 |
Why?
|
| Lymphoma, Follicular | 10 | 2022 | 435 | 1.260 |
Why?
|
| Leukocytosis | 4 | 2016 | 247 | 1.260 |
Why?
|
| Neoplasms, Second Primary | 5 | 2023 | 1061 | 1.210 |
Why?
|
| Reticulin | 4 | 2014 | 21 | 1.170 |
Why?
|
| Immunophenotyping | 25 | 2022 | 1880 | 1.140 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 7 | 2020 | 689 | 1.120 |
Why?
|
| Primary Myelofibrosis | 7 | 2023 | 215 | 1.110 |
Why?
|
| Janus Kinase 2 | 13 | 2023 | 528 | 1.080 |
Why?
|
| Chromosome Deletion | 4 | 2017 | 1401 | 1.030 |
Why?
|
| Diagnosis, Differential | 48 | 2022 | 12959 | 1.010 |
Why?
|
| Prognosis | 48 | 2023 | 29063 | 0.970 |
Why?
|
| Calreticulin | 4 | 2020 | 98 | 0.960 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 10 | 2022 | 491 | 0.940 |
Why?
|
| Hypereosinophilic Syndrome | 4 | 2023 | 93 | 0.940 |
Why?
|
| Lymph Nodes | 13 | 2021 | 3474 | 0.930 |
Why?
|
| Hematologic Diseases | 4 | 2023 | 498 | 0.920 |
Why?
|
| Bone Marrow Examination | 10 | 2017 | 157 | 0.900 |
Why?
|
| Tandem Repeat Sequences | 2 | 2022 | 185 | 0.880 |
Why?
|
| Bone Marrow Cells | 10 | 2021 | 2513 | 0.870 |
Why?
|
| Thrombocythemia, Essential | 3 | 2018 | 105 | 0.850 |
Why?
|
| Karyotyping | 9 | 2017 | 1243 | 0.850 |
Why?
|
| Leukemia, Eosinophilic, Acute | 1 | 2021 | 5 | 0.830 |
Why?
|
| Humans | 261 | 2023 | 744343 | 0.820 |
Why?
|
| Leukemia | 10 | 2023 | 1511 | 0.810 |
Why?
|
| Nuclear Proteins | 19 | 2023 | 5853 | 0.800 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 4 | 2020 | 97 | 0.780 |
Why?
|
| Oral Ulcer | 1 | 2021 | 96 | 0.760 |
Why?
|
| Biopsy | 29 | 2023 | 6756 | 0.760 |
Why?
|
| Tumor Suppressor Protein p53 | 8 | 2022 | 2948 | 0.750 |
Why?
|
| Core Binding Factors | 1 | 2020 | 31 | 0.740 |
Why?
|
| Lymphoma, B-Cell | 7 | 2015 | 931 | 0.740 |
Why?
|
| Flow Cytometry | 15 | 2022 | 5974 | 0.730 |
Why?
|
| Aged, 80 and over | 63 | 2022 | 57776 | 0.720 |
Why?
|
| Chromosomes, Human, Pair 20 | 2 | 2011 | 133 | 0.710 |
Why?
|
| Herpesvirus 4, Human | 9 | 2022 | 1041 | 0.700 |
Why?
|
| Neoplasm Proteins | 6 | 2022 | 3703 | 0.690 |
Why?
|
| Bone Marrow Neoplasms | 2 | 2011 | 104 | 0.680 |
Why?
|
| Thymus Neoplasms | 4 | 2015 | 268 | 0.680 |
Why?
|
| Aged | 99 | 2022 | 163280 | 0.660 |
Why?
|
| Pancytopenia | 4 | 2016 | 104 | 0.660 |
Why?
|
| Pathology, Clinical | 2 | 2019 | 368 | 0.640 |
Why?
|
| Gene Rearrangement | 9 | 2022 | 1179 | 0.640 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2020 | 214 | 0.630 |
Why?
|
| Fusion Proteins, bcr-abl | 3 | 2018 | 434 | 0.630 |
Why?
|
| Ring Chromosomes | 1 | 2017 | 22 | 0.620 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 2 | 2019 | 177 | 0.620 |
Why?
|
| Polycythemia Vera | 3 | 2017 | 164 | 0.600 |
Why?
|
| Male | 140 | 2022 | 350118 | 0.600 |
Why?
|
| Phosphoproteins | 4 | 2020 | 2440 | 0.600 |
Why?
|
| Chromosome Inversion | 2 | 2017 | 127 | 0.590 |
Why?
|
| Abdomen | 1 | 2023 | 1118 | 0.590 |
Why?
|
| Receptors, Colony-Stimulating Factor | 1 | 2016 | 49 | 0.580 |
Why?
|
| Hematology | 2 | 2023 | 221 | 0.580 |
Why?
|
| Adult | 106 | 2023 | 214055 | 0.580 |
Why?
|
| Burkitt Lymphoma | 3 | 2010 | 327 | 0.580 |
Why?
|
| Dendritic Cell Sarcoma, Follicular | 3 | 2022 | 30 | 0.570 |
Why?
|
| Biological Products | 2 | 2023 | 860 | 0.570 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 3 | 2021 | 134 | 0.570 |
Why?
|
| Megakaryocytes | 4 | 2018 | 545 | 0.570 |
Why?
|
| Middle Aged | 110 | 2022 | 213383 | 0.570 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 8 | 2016 | 1378 | 0.560 |
Why?
|
| Killer Cells, Natural | 2 | 2021 | 2133 | 0.560 |
Why?
|
| Epstein-Barr Virus Infections | 5 | 2022 | 570 | 0.550 |
Why?
|
| Mastocytosis, Systemic | 2 | 2023 | 100 | 0.550 |
Why?
|
| Lymphoma, Non-Hodgkin | 4 | 2015 | 1381 | 0.550 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2021 | 1519 | 0.530 |
Why?
|
| Fatal Outcome | 12 | 2012 | 1850 | 0.530 |
Why?
|
| Neoplasm, Residual | 5 | 2022 | 973 | 0.530 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 1 | 2015 | 48 | 0.530 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2017 | 354 | 0.520 |
Why?
|
| Anemia, Macrocytic | 1 | 2015 | 55 | 0.520 |
Why?
|
| Chromosomes, Human | 1 | 2017 | 457 | 0.520 |
Why?
|
| Genetic Testing | 3 | 2019 | 3444 | 0.520 |
Why?
|
| Female | 126 | 2023 | 380194 | 0.510 |
Why?
|
| DNA Copy Number Variations | 3 | 2022 | 1941 | 0.510 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2017 | 345 | 0.510 |
Why?
|
| Anemia, Refractory, with Excess of Blasts | 1 | 2014 | 17 | 0.500 |
Why?
|
| Myeloid Cells | 3 | 2018 | 810 | 0.500 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 11 | 2021 | 5442 | 0.500 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 14 | 2019 | 11524 | 0.490 |
Why?
|
| Immunohistochemistry | 27 | 2022 | 11366 | 0.490 |
Why?
|
| Thymoma | 2 | 2007 | 186 | 0.490 |
Why?
|
| Mediastinal Neoplasms | 3 | 2016 | 423 | 0.480 |
Why?
|
| DNA Mutational Analysis | 11 | 2022 | 4186 | 0.470 |
Why?
|
| Kaplan-Meier Estimate | 13 | 2019 | 6538 | 0.470 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 3 | 2022 | 260 | 0.450 |
Why?
|
| Sarcoma, Myeloid | 4 | 2023 | 59 | 0.440 |
Why?
|
| Precancerous Conditions | 2 | 2019 | 975 | 0.440 |
Why?
|
| Eosinophilia | 4 | 2021 | 541 | 0.430 |
Why?
|
| Neoplasms | 14 | 2023 | 21683 | 0.430 |
Why?
|
| T-Lymphocytes | 7 | 2018 | 10180 | 0.430 |
Why?
|
| Cytogenetic Analysis | 7 | 2022 | 295 | 0.410 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 3 | 2023 | 294 | 0.410 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 | 2015 | 1596 | 0.410 |
Why?
|
| Erythroid Cells | 3 | 2021 | 238 | 0.410 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2016 | 602 | 0.410 |
Why?
|
| Antigens, CD20 | 3 | 2009 | 199 | 0.400 |
Why?
|
| Stem Cell Transplantation | 4 | 2018 | 1620 | 0.400 |
Why?
|
| Thrombocytopenia | 4 | 2015 | 1179 | 0.400 |
Why?
|
| Cytogenetics | 4 | 2022 | 203 | 0.400 |
Why?
|
| Genomics | 7 | 2022 | 5720 | 0.400 |
Why?
|
| Young Adult | 37 | 2022 | 56430 | 0.400 |
Why?
|
| Lymphoproliferative Disorders | 2 | 2018 | 523 | 0.400 |
Why?
|
| Lymphomatoid Granulomatosis | 2 | 2011 | 16 | 0.390 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 3 | 2022 | 169 | 0.390 |
Why?
|
| Red-Cell Aplasia, Pure | 2 | 2007 | 30 | 0.390 |
Why?
|
| Pyoderma Gangrenosum | 1 | 2012 | 76 | 0.380 |
Why?
|
| Acute Kidney Injury | 1 | 2023 | 1972 | 0.380 |
Why?
|
| Lymphoma | 7 | 2022 | 1877 | 0.380 |
Why?
|
| Ulcer | 1 | 2012 | 209 | 0.370 |
Why?
|
| Lymphocytosis | 1 | 2011 | 119 | 0.370 |
Why?
|
| Sarcoma | 4 | 2021 | 1897 | 0.370 |
Why?
|
| Herpesvirus 8, Human | 3 | 2014 | 258 | 0.370 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 3 | 2009 | 233 | 0.370 |
Why?
|
| Lymphoma, T-Cell | 3 | 2009 | 299 | 0.360 |
Why?
|
| Ear Neoplasms | 1 | 2010 | 117 | 0.360 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2022 | 1434 | 0.350 |
Why?
|
| Receptors, Thrombopoietin | 4 | 2020 | 157 | 0.350 |
Why?
|
| Ki-67 Antigen | 3 | 2012 | 644 | 0.350 |
Why?
|
| Erythroid Precursor Cells | 2 | 2008 | 218 | 0.350 |
Why?
|
| Classification | 1 | 2009 | 129 | 0.350 |
Why?
|
| Erythroblasts | 2 | 2010 | 150 | 0.340 |
Why?
|
| Retrospective Studies | 31 | 2023 | 77449 | 0.340 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2010 | 403 | 0.330 |
Why?
|
| Rectum | 1 | 2014 | 904 | 0.330 |
Why?
|
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2 | 2021 | 10 | 0.330 |
Why?
|
| Lymphocytes | 3 | 2014 | 2617 | 0.330 |
Why?
|
| Limbic Encephalitis | 1 | 2008 | 34 | 0.330 |
Why?
|
| Splenomegaly | 3 | 2016 | 190 | 0.330 |
Why?
|
| Remission Induction | 4 | 2020 | 2386 | 0.330 |
Why?
|
| Fibrosis | 6 | 2023 | 2029 | 0.320 |
Why?
|
| Hematopoiesis | 7 | 2022 | 2072 | 0.320 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2012 | 547 | 0.310 |
Why?
|
| Neoplastic Stem Cells | 6 | 2020 | 1376 | 0.310 |
Why?
|
| Cell Proliferation | 5 | 2020 | 10481 | 0.310 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2021 | 222 | 0.310 |
Why?
|
| Adolescent | 35 | 2022 | 85781 | 0.300 |
Why?
|
| In Situ Hybridization, Fluorescence | 11 | 2022 | 2649 | 0.300 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2020 | 20129 | 0.300 |
Why?
|
| Carcinoid Tumor | 1 | 2008 | 235 | 0.290 |
Why?
|
| Survival Rate | 10 | 2020 | 12788 | 0.290 |
Why?
|
| High-Throughput Nucleotide Sequencing | 7 | 2021 | 3597 | 0.290 |
Why?
|
| Hematopoietic Stem Cells | 7 | 2020 | 3386 | 0.280 |
Why?
|
| Oncogene Proteins, Fusion | 5 | 2018 | 1581 | 0.280 |
Why?
|
| Disease-Free Survival | 9 | 2020 | 6895 | 0.280 |
Why?
|
| Thymus Gland | 2 | 2005 | 1267 | 0.280 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 547 | 0.270 |
Why?
|
| Bone Marrow Diseases | 1 | 2008 | 231 | 0.270 |
Why?
|
| Anemia, Diamond-Blackfan | 1 | 2006 | 137 | 0.260 |
Why?
|
| Disease Progression | 13 | 2021 | 13284 | 0.260 |
Why?
|
| Algorithms | 6 | 2018 | 13881 | 0.260 |
Why?
|
| Pathology | 1 | 2008 | 272 | 0.250 |
Why?
|
| Child | 24 | 2023 | 77709 | 0.250 |
Why?
|
| Genomic Instability | 2 | 2020 | 695 | 0.250 |
Why?
|
| Fatigue | 4 | 2016 | 1531 | 0.240 |
Why?
|
| In Situ Hybridization | 6 | 2014 | 1950 | 0.240 |
Why?
|
| Pilonidal Sinus | 1 | 2004 | 16 | 0.240 |
Why?
|
| Biopsy, Fine-Needle | 6 | 2022 | 1094 | 0.240 |
Why?
|
| Cell Count | 5 | 2018 | 1856 | 0.240 |
Why?
|
| Early Detection of Cancer | 1 | 2018 | 3086 | 0.240 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2021 | 651 | 0.240 |
Why?
|
| beta-Thalassemia | 1 | 2006 | 225 | 0.230 |
Why?
|
| Survival Analysis | 10 | 2020 | 10252 | 0.230 |
Why?
|
| Thrombocytosis | 2 | 2018 | 81 | 0.230 |
Why?
|
| Sequence Deletion | 3 | 2007 | 1526 | 0.230 |
Why?
|
| Fetal Hemoglobin | 1 | 2006 | 341 | 0.230 |
Why?
|
| Fanconi Anemia | 1 | 2006 | 319 | 0.230 |
Why?
|
| Sarcoma, Kaposi | 1 | 2006 | 370 | 0.230 |
Why?
|
| Oncogene Fusion | 2 | 2021 | 99 | 0.230 |
Why?
|
| Transplantation, Homologous | 5 | 2021 | 4776 | 0.230 |
Why?
|
| Hearing Loss | 1 | 2010 | 765 | 0.220 |
Why?
|
| Lymphoma, Extranodal NK-T-Cell | 2 | 2016 | 44 | 0.220 |
Why?
|
| Stromal Cells | 2 | 2010 | 1355 | 0.220 |
Why?
|
| Autoimmune Diseases | 2 | 2018 | 2133 | 0.220 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2023 | 125 | 0.220 |
Why?
|
| Bone Neoplasms | 3 | 2016 | 2529 | 0.220 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2006 | 657 | 0.220 |
Why?
|
| Pyrrolidines | 2 | 2015 | 342 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 11 | 3 | 2013 | 417 | 0.210 |
Why?
|
| Predictive Value of Tests | 10 | 2018 | 15076 | 0.210 |
Why?
|
| Isochromosomes | 1 | 2021 | 16 | 0.210 |
Why?
|
| Amyloid | 1 | 2007 | 795 | 0.210 |
Why?
|
| Chemokine CXCL13 | 1 | 2021 | 54 | 0.200 |
Why?
|
| Cell Shape | 3 | 2023 | 375 | 0.200 |
Why?
|
| Receptors, CXCR5 | 1 | 2021 | 92 | 0.200 |
Why?
|
| Gene Frequency | 5 | 2021 | 3588 | 0.200 |
Why?
|
| Testicular Neoplasms | 2 | 2007 | 804 | 0.200 |
Why?
|
| Macrophage Activation Syndrome | 1 | 2022 | 111 | 0.200 |
Why?
|
| Acute Disease | 7 | 2023 | 7149 | 0.200 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2021 | 17446 | 0.200 |
Why?
|
| Antineoplastic Agents | 9 | 2022 | 13695 | 0.190 |
Why?
|
| Monocytes | 4 | 2017 | 2596 | 0.190 |
Why?
|
| Monocyte-Macrophage Precursor Cells | 1 | 2020 | 5 | 0.190 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 2 | 2018 | 102 | 0.190 |
Why?
|
| Testis | 1 | 2004 | 803 | 0.190 |
Why?
|
| Blast Crisis | 2 | 2020 | 103 | 0.190 |
Why?
|
| Amyloidosis | 1 | 2007 | 795 | 0.180 |
Why?
|
| Immunologic Factors | 1 | 2009 | 1580 | 0.180 |
Why?
|
| Chromosomes, Human, Y | 1 | 2021 | 148 | 0.180 |
Why?
|
| Mastocytosis | 2 | 2020 | 160 | 0.180 |
Why?
|
| Treatment Outcome | 21 | 2023 | 63114 | 0.180 |
Why?
|
| Philadelphia Chromosome | 3 | 2017 | 112 | 0.180 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2021 | 142 | 0.170 |
Why?
|
| Tumor Microenvironment | 3 | 2021 | 3586 | 0.170 |
Why?
|
| Translocation, Genetic | 6 | 2014 | 1420 | 0.170 |
Why?
|
| RNA, Viral | 4 | 2014 | 2902 | 0.170 |
Why?
|
| Proportional Hazards Models | 6 | 2019 | 12354 | 0.170 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2022 | 560 | 0.170 |
Why?
|
| Education | 2 | 2019 | 543 | 0.170 |
Why?
|
| Skin | 2 | 2013 | 4364 | 0.170 |
Why?
|
| Carcinoma | 2 | 2005 | 2375 | 0.170 |
Why?
|
| Germinal Center | 2 | 2015 | 377 | 0.170 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2018 | 53 | 0.160 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 2 | 2010 | 180 | 0.160 |
Why?
|
| RNA, Neoplasm | 1 | 2021 | 769 | 0.160 |
Why?
|
| Genetic Association Studies | 2 | 2019 | 2703 | 0.160 |
Why?
|
| Multiple Organ Failure | 1 | 2021 | 390 | 0.160 |
Why?
|
| DNA Methylation | 4 | 2018 | 4286 | 0.160 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 7913 | 0.160 |
Why?
|
| Child, Preschool | 12 | 2021 | 41006 | 0.160 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2023 | 8949 | 0.160 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2020 | 407 | 0.160 |
Why?
|
| Terminology as Topic | 4 | 2014 | 1547 | 0.160 |
Why?
|
| Gene Fusion | 1 | 2021 | 371 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 9 | 3 | 2018 | 535 | 0.160 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2020 | 302 | 0.160 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2014 | 640 | 0.160 |
Why?
|
| Pyrimidines | 4 | 2015 | 2942 | 0.160 |
Why?
|
| DNA, Neoplasm | 3 | 2021 | 1758 | 0.160 |
Why?
|
| Mosaicism | 1 | 2021 | 441 | 0.160 |
Why?
|
| Gene Deletion | 4 | 2018 | 2751 | 0.150 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2020 | 670 | 0.150 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2006 | 2232 | 0.150 |
Why?
|
| Anemia | 4 | 2023 | 1506 | 0.150 |
Why?
|
| Neoplasm Staging | 9 | 2016 | 11031 | 0.150 |
Why?
|
| Sulfonamides | 3 | 2020 | 1938 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2012 | 4479 | 0.150 |
Why?
|
| Receptors, IgE | 1 | 1999 | 389 | 0.150 |
Why?
|
| Neutrophils | 2 | 2022 | 3719 | 0.150 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2018 | 151 | 0.150 |
Why?
|
| Isocitrate Dehydrogenase | 3 | 2021 | 871 | 0.150 |
Why?
|
| Immunosuppressive Agents | 2 | 2009 | 4149 | 0.140 |
Why?
|
| Thyroid Neoplasms | 2 | 2011 | 2282 | 0.140 |
Why?
|
| Radiography | 5 | 2013 | 7023 | 0.140 |
Why?
|
| Interferon Regulatory Factors | 2 | 2016 | 270 | 0.140 |
Why?
|
| Consensus | 5 | 2023 | 2959 | 0.140 |
Why?
|
| Cytarabine | 2 | 2019 | 692 | 0.140 |
Why?
|
| Anti-Infective Agents | 1 | 2004 | 972 | 0.140 |
Why?
|
| Sweating | 1 | 2016 | 123 | 0.140 |
Why?
|
| Herpesviridae Infections | 2 | 2014 | 277 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 4 | 2010 | 9274 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2020 | 776 | 0.130 |
Why?
|
| Liver | 3 | 2008 | 7474 | 0.130 |
Why?
|
| Combined Modality Therapy | 5 | 2009 | 8642 | 0.130 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2015 | 21 | 0.130 |
Why?
|
| Cultural Diversity | 1 | 2019 | 359 | 0.130 |
Why?
|
| New York City | 1 | 2017 | 710 | 0.130 |
Why?
|
| Age Factors | 5 | 2016 | 18370 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2022 | 5535 | 0.130 |
Why?
|
| Trisomy | 1 | 2016 | 266 | 0.130 |
Why?
|
| Parvovirus B19, Human | 2 | 2012 | 38 | 0.130 |
Why?
|
| Boston | 4 | 2017 | 9313 | 0.130 |
Why?
|
| Blood Cells | 1 | 2016 | 309 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 7 | 2013 | 6171 | 0.120 |
Why?
|
| Fever | 3 | 2008 | 1616 | 0.120 |
Why?
|
| Liver Neoplasms | 2 | 2010 | 4253 | 0.120 |
Why?
|
| Microfluidics | 1 | 2020 | 662 | 0.120 |
Why?
|
| Facial Neoplasms | 2 | 2009 | 121 | 0.120 |
Why?
|
| Anemia, Sideroblastic | 1 | 2015 | 101 | 0.120 |
Why?
|
| Phenotype | 8 | 2021 | 16365 | 0.120 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2016 | 234 | 0.120 |
Why?
|
| Blotting, Southern | 2 | 2011 | 803 | 0.120 |
Why?
|
| Reproducibility of Results | 6 | 2023 | 19905 | 0.120 |
Why?
|
| Bradyrhizobium | 1 | 2013 | 17 | 0.120 |
Why?
|
| Janus Kinases | 1 | 2015 | 244 | 0.120 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2006 | 4386 | 0.120 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2006 | 2214 | 0.120 |
Why?
|
| Recombinant Proteins | 1 | 2023 | 6622 | 0.120 |
Why?
|
| Antigens, CD | 6 | 2013 | 4026 | 0.110 |
Why?
|
| Soft Tissue Neoplasms | 2 | 2020 | 1363 | 0.110 |
Why?
|
| Recurrence | 5 | 2020 | 8340 | 0.110 |
Why?
|
| Retroperitoneal Fibrosis | 1 | 2013 | 37 | 0.110 |
Why?
|
| Reed-Sternberg Cells | 2 | 2012 | 73 | 0.110 |
Why?
|
| Transplantation Conditioning | 1 | 2020 | 1598 | 0.110 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 2 | 2013 | 286 | 0.110 |
Why?
|
| Crohn Disease | 1 | 2006 | 2303 | 0.110 |
Why?
|
| Leukocyte Count | 2 | 2017 | 1588 | 0.110 |
Why?
|
| Cerebrospinal Fluid | 2 | 2007 | 534 | 0.110 |
Why?
|
| Spleen | 1 | 1999 | 2362 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2019 | 8428 | 0.110 |
Why?
|
| Rhabdoid Tumor | 1 | 1995 | 212 | 0.110 |
Why?
|
| Kidney Transplantation | 1 | 2008 | 4251 | 0.110 |
Why?
|
| Pain | 3 | 2021 | 4986 | 0.110 |
Why?
|
| Histiocytic Necrotizing Lymphadenitis | 1 | 2012 | 23 | 0.110 |
Why?
|
| Dioxygenases | 3 | 2020 | 316 | 0.110 |
Why?
|
| Dexamethasone | 1 | 2020 | 1951 | 0.110 |
Why?
|
| Switzerland | 1 | 2013 | 255 | 0.110 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2018 | 736 | 0.110 |
Why?
|
| Azacitidine | 2 | 2016 | 347 | 0.110 |
Why?
|
| Immunoconjugates | 1 | 2019 | 901 | 0.110 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2011 | 29 | 0.100 |
Why?
|
| Medical Oncology | 2 | 2022 | 2265 | 0.100 |
Why?
|
| Herpesvirus 6, Human | 1 | 2012 | 95 | 0.100 |
Why?
|
| Infectious Mononucleosis | 1 | 2012 | 131 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2013 | 373 | 0.100 |
Why?
|
| Sweet Syndrome | 1 | 2012 | 47 | 0.100 |
Why?
|
| Diarrhea | 3 | 2014 | 1348 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 3 | 2018 | 4803 | 0.100 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2013 | 236 | 0.100 |
Why?
|
| Lung | 3 | 2008 | 9856 | 0.100 |
Why?
|
| Submandibular Gland Neoplasms | 1 | 2011 | 11 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2013 | 437 | 0.100 |
Why?
|
| Endocrine Gland Neoplasms | 1 | 2011 | 25 | 0.100 |
Why?
|
| Cell Differentiation | 8 | 2021 | 11483 | 0.100 |
Why?
|
| Piperazines | 1 | 2002 | 2488 | 0.100 |
Why?
|
| Maryland | 1 | 2011 | 276 | 0.100 |
Why?
|
| Minority Groups | 1 | 2019 | 1223 | 0.100 |
Why?
|
| Otitis | 1 | 2010 | 20 | 0.100 |
Why?
|
| Flushing | 1 | 2011 | 49 | 0.100 |
Why?
|
| Hepatomegaly | 1 | 2010 | 85 | 0.100 |
Why?
|
| Mouth Neoplasms | 1 | 2016 | 601 | 0.090 |
Why?
|
| Otorhinolaryngologic Neoplasms | 1 | 2010 | 25 | 0.090 |
Why?
|
| Phthalazines | 1 | 2013 | 363 | 0.090 |
Why?
|
| Neutrophil Infiltration | 1 | 2013 | 390 | 0.090 |
Why?
|
| Transcription Factors | 7 | 2023 | 12208 | 0.090 |
Why?
|
| Immunoglobulin Light Chains | 2 | 2012 | 277 | 0.090 |
Why?
|
| Lung Neoplasms | 3 | 2015 | 13102 | 0.090 |
Why?
|
| Histiocytosis, Sinus | 1 | 2010 | 47 | 0.090 |
Why?
|
| North America | 1 | 2014 | 1249 | 0.090 |
Why?
|
| Opportunistic Infections | 1 | 2013 | 389 | 0.090 |
Why?
|
| Hemangioma, Capillary | 1 | 2010 | 61 | 0.090 |
Why?
|
| Splenic Neoplasms | 1 | 2010 | 100 | 0.090 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2006 | 2455 | 0.090 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2010 | 57 | 0.090 |
Why?
|
| Brain Neoplasms | 2 | 2006 | 8863 | 0.090 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2010 | 92 | 0.090 |
Why?
|
| Skin Neoplasms | 2 | 2023 | 5686 | 0.090 |
Why?
|
| Receptors, Cell Surface | 5 | 1997 | 2866 | 0.090 |
Why?
|
| Cell Nucleus | 2 | 2018 | 2969 | 0.090 |
Why?
|
| Belgium | 1 | 2009 | 103 | 0.090 |
Why?
|
| Blood Cell Count | 2 | 2016 | 403 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2020 | 4554 | 0.090 |
Why?
|
| Ribs | 1 | 2011 | 252 | 0.090 |
Why?
|
| Stomach | 1 | 2014 | 697 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2000 | 3617 | 0.090 |
Why?
|
| Atrophy | 1 | 2014 | 1583 | 0.080 |
Why?
|
| Membrane Proteins | 5 | 1997 | 7880 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 1526 | 0.080 |
Why?
|
| Chromosomes, Human, X | 1 | 2010 | 296 | 0.080 |
Why?
|
| Cohort Studies | 4 | 2023 | 40561 | 0.080 |
Why?
|
| Internationality | 1 | 2014 | 1003 | 0.080 |
Why?
|
| B-Lymphocytes | 4 | 2022 | 4665 | 0.080 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2010 | 171 | 0.080 |
Why?
|
| Hamartoma | 1 | 2010 | 238 | 0.080 |
Why?
|
| X Chromosome Inactivation | 1 | 2010 | 224 | 0.080 |
Why?
|
| Interphase | 1 | 2008 | 226 | 0.080 |
Why?
|
| Dyspnea | 2 | 2006 | 1303 | 0.080 |
Why?
|
| Neck | 1 | 2013 | 697 | 0.080 |
Why?
|
| Follow-Up Studies | 8 | 2019 | 39050 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2018 | 2942 | 0.080 |
Why?
|
| Observer Variation | 1 | 2014 | 2593 | 0.080 |
Why?
|
| Necrosis | 3 | 2012 | 1643 | 0.080 |
Why?
|
| Lipodystrophy, Congenital Generalized | 1 | 2007 | 9 | 0.080 |
Why?
|
| Platelet Count | 1 | 2010 | 781 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 3 | 2007 | 1799 | 0.080 |
Why?
|
| Pyrazoles | 2 | 2015 | 1972 | 0.080 |
Why?
|
| Mediastinum | 1 | 2008 | 267 | 0.070 |
Why?
|
| Graft vs Host Disease | 3 | 2013 | 2957 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 3 | 2018 | 3616 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2020 | 5172 | 0.070 |
Why?
|
| Positron-Emission Tomography | 4 | 2011 | 6234 | 0.070 |
Why?
|
| Anemia, Refractory | 1 | 2006 | 17 | 0.070 |
Why?
|
| Zebrafish | 1 | 2018 | 2994 | 0.070 |
Why?
|
| Fetal Blood | 1 | 2013 | 1318 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2020 | 3327 | 0.070 |
Why?
|
| Mediastinal Diseases | 1 | 2007 | 89 | 0.070 |
Why?
|
| Lyme Neuroborreliosis | 1 | 2007 | 51 | 0.070 |
Why?
|
| Confusion | 1 | 2008 | 275 | 0.070 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2007 | 65 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2013 | 35421 | 0.070 |
Why?
|
| Hand | 1 | 2012 | 884 | 0.070 |
Why?
|
| Gastroenteritis | 1 | 2008 | 245 | 0.070 |
Why?
|
| Thoracic Vertebrae | 1 | 2011 | 608 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 3508 | 0.070 |
Why?
|
| Bone Marrow Transplantation | 3 | 2020 | 2765 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 3462 | 0.070 |
Why?
|
| Temporal Bone | 1 | 2010 | 661 | 0.070 |
Why?
|
| Hematocrit | 1 | 2007 | 636 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2008 | 342 | 0.070 |
Why?
|
| Conjunctival Neoplasms | 1 | 2007 | 79 | 0.070 |
Why?
|
| Cough | 1 | 2009 | 555 | 0.070 |
Why?
|
| Groin | 1 | 2006 | 104 | 0.070 |
Why?
|
| Receptors, Fc | 1 | 2009 | 541 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 4 | 2021 | 6386 | 0.070 |
Why?
|
| Point Mutation | 2 | 2010 | 1623 | 0.070 |
Why?
|
| Elbow | 1 | 2006 | 138 | 0.070 |
Why?
|
| Prealbumin | 1 | 2007 | 210 | 0.070 |
Why?
|
| Epididymis | 1 | 2007 | 227 | 0.070 |
Why?
|
| Time Factors | 4 | 2017 | 40075 | 0.070 |
Why?
|
| Animals | 23 | 2023 | 168757 | 0.070 |
Why?
|
| Thyroiditis | 1 | 2005 | 85 | 0.060 |
Why?
|
| Borrelia burgdorferi | 1 | 2007 | 180 | 0.060 |
Why?
|
| Sclerosis | 1 | 2005 | 213 | 0.060 |
Why?
|
| Gastric Mucosa | 1 | 2008 | 599 | 0.060 |
Why?
|
| DNA-Binding Proteins | 6 | 2020 | 9648 | 0.060 |
Why?
|
| Colon | 1 | 2013 | 1772 | 0.060 |
Why?
|
| Colitis | 1 | 2013 | 1170 | 0.060 |
Why?
|
| Dendritic Cells | 3 | 2023 | 2725 | 0.060 |
Why?
|
| Encephalitis | 1 | 2008 | 423 | 0.060 |
Why?
|
| Hypotension | 1 | 2011 | 884 | 0.060 |
Why?
|
| Eye Neoplasms | 1 | 2007 | 313 | 0.060 |
Why?
|
| Lymphatic Diseases | 1 | 2006 | 324 | 0.060 |
Why?
|
| Orbital Neoplasms | 1 | 2007 | 225 | 0.060 |
Why?
|
| Immune Complex Diseases | 1 | 2004 | 54 | 0.060 |
Why?
|
| Skin Diseases | 1 | 2013 | 1065 | 0.060 |
Why?
|
| Photophobia | 1 | 2005 | 67 | 0.060 |
Why?
|
| Neural Tube Defects | 1 | 2006 | 256 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2010 | 987 | 0.060 |
Why?
|
| Immunocompromised Host | 2 | 2013 | 847 | 0.060 |
Why?
|
| Risk Factors | 5 | 2023 | 72290 | 0.060 |
Why?
|
| Serum Amyloid P-Component | 1 | 2004 | 47 | 0.060 |
Why?
|
| Biopsy, Needle | 2 | 2011 | 1641 | 0.060 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2003 | 1821 | 0.060 |
Why?
|
| Iron Overload | 1 | 2006 | 242 | 0.060 |
Why?
|
| Mice | 17 | 2022 | 81183 | 0.060 |
Why?
|
| Unconsciousness | 1 | 2006 | 263 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2012 | 21746 | 0.060 |
Why?
|
| Cytoplasm | 2 | 2007 | 1539 | 0.060 |
Why?
|
| Anaphylaxis | 1 | 2011 | 746 | 0.060 |
Why?
|
| Thiazoles | 1 | 2011 | 1483 | 0.060 |
Why?
|
| Fibrinogen | 1 | 2007 | 894 | 0.060 |
Why?
|
| Contraceptives, Oral | 1 | 2006 | 564 | 0.060 |
Why?
|
| Neck Pain | 1 | 2005 | 180 | 0.060 |
Why?
|
| Carrier Proteins | 3 | 2009 | 5021 | 0.060 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2011 | 990 | 0.060 |
Why?
|
| United States | 8 | 2019 | 69872 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2021 | 9239 | 0.060 |
Why?
|
| Meningitis | 1 | 2005 | 216 | 0.060 |
Why?
|
| Risk Assessment | 4 | 2023 | 23338 | 0.060 |
Why?
|
| Receptor, Notch1 | 5 | 1997 | 502 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2010 | 9146 | 0.060 |
Why?
|
| Alleles | 3 | 2020 | 6933 | 0.060 |
Why?
|
| Skin Ulcer | 1 | 2004 | 120 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9438 | 0.050 |
Why?
|
| Leukemia, Myeloid, Chronic-Phase | 2 | 2000 | 38 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2011 | 2016 | 0.050 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2006 | 693 | 0.050 |
Why?
|
| Repressor Proteins | 3 | 2017 | 3023 | 0.050 |
Why?
|
| WT1 Proteins | 1 | 2003 | 178 | 0.050 |
Why?
|
| Blood | 1 | 2005 | 598 | 0.050 |
Why?
|
| Bone Diseases | 1 | 2006 | 416 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2010 | 1988 | 0.050 |
Why?
|
| Glomerulonephritis | 1 | 2004 | 372 | 0.050 |
Why?
|
| Clone Cells | 2 | 2019 | 1692 | 0.050 |
Why?
|
| Poly(A)-Binding Protein I | 1 | 2021 | 14 | 0.050 |
Why?
|
| Antigens, CD34 | 2 | 2020 | 657 | 0.050 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 2018 | 501 | 0.050 |
Why?
|
| Colitis, Ulcerative | 1 | 2014 | 1912 | 0.050 |
Why?
|
| Leukocytes | 2 | 2022 | 2043 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 2886 | 0.050 |
Why?
|
| Ovary | 1 | 2006 | 981 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2011 | 2645 | 0.050 |
Why?
|
| Memory Disorders | 1 | 2008 | 1184 | 0.050 |
Why?
|
| Abdominal Pain | 1 | 2008 | 1063 | 0.050 |
Why?
|
| Pyridines | 1 | 2013 | 2825 | 0.050 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2009 | 808 | 0.050 |
Why?
|
| HIV Infections | 1 | 2007 | 16718 | 0.050 |
Why?
|
| Infant | 5 | 2016 | 35136 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 4560 | 0.050 |
Why?
|
| Temporal Lobe | 1 | 2008 | 1670 | 0.050 |
Why?
|
| Heart Diseases | 1 | 2014 | 2788 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2014 | 5985 | 0.050 |
Why?
|
| Hypothyroidism | 1 | 2005 | 658 | 0.050 |
Why?
|
| Mice, Inbred NOD | 4 | 2013 | 1878 | 0.050 |
Why?
|
| Thyroidectomy | 1 | 2005 | 879 | 0.050 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2000 | 202 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2008 | 1838 | 0.040 |
Why?
|
| Europe | 2 | 2017 | 3339 | 0.040 |
Why?
|
| Epithelioid Cells | 1 | 2020 | 71 | 0.040 |
Why?
|
| Radiography, Thoracic | 1 | 2006 | 1265 | 0.040 |
Why?
|
| Receptors, Parathyroid Hormone | 1 | 2000 | 332 | 0.040 |
Why?
|
| Cytological Techniques | 1 | 2021 | 219 | 0.040 |
Why?
|
| Mitoxantrone | 1 | 2019 | 152 | 0.040 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 2015 | 659 | 0.040 |
Why?
|
| Nitriles | 2 | 2015 | 956 | 0.040 |
Why?
|
| Mice, SCID | 4 | 2013 | 2716 | 0.040 |
Why?
|
| Rheumatic Diseases | 1 | 2006 | 592 | 0.040 |
Why?
|
| Splenectomy | 1 | 2021 | 395 | 0.040 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2020 | 212 | 0.040 |
Why?
|
| Endometrium | 1 | 2022 | 424 | 0.040 |
Why?
|
| Salmonella typhi | 1 | 2001 | 201 | 0.040 |
Why?
|
| Typhoid Fever | 1 | 2001 | 197 | 0.040 |
Why?
|
| Central Nervous System | 2 | 2022 | 1357 | 0.040 |
Why?
|
| Hemolysis | 1 | 2021 | 420 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2010 | 2575 | 0.040 |
Why?
|
| Brain | 1 | 2006 | 26385 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2021 | 3798 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 4328 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12245 | 0.040 |
Why?
|
| Genotype | 2 | 2019 | 12951 | 0.040 |
Why?
|
| Leukemia, T-Cell | 2 | 1996 | 104 | 0.040 |
Why?
|
| Neutropenia | 1 | 2004 | 895 | 0.040 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1999 | 180 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2019 | 5788 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2012 | 2988 | 0.040 |
Why?
|
| Stem Cell Niche | 2 | 2013 | 346 | 0.040 |
Why?
|
| Indazoles | 1 | 2020 | 289 | 0.040 |
Why?
|
| Echocardiography | 1 | 2011 | 5102 | 0.040 |
Why?
|
| Pedigree | 1 | 2006 | 4644 | 0.040 |
Why?
|
| Etoposide | 1 | 2019 | 641 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 234 | 0.040 |
Why?
|
| Staining and Labeling | 2 | 2017 | 1100 | 0.040 |
Why?
|
| Thyroid Hormones | 1 | 2000 | 390 | 0.040 |
Why?
|
| Uterus | 1 | 2022 | 711 | 0.040 |
Why?
|
| Loss of Heterozygosity | 1 | 2020 | 684 | 0.040 |
Why?
|
| ras Proteins | 2 | 2018 | 1060 | 0.040 |
Why?
|
| Workflow | 1 | 2022 | 847 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2018 | 2085 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2011 | 6442 | 0.040 |
Why?
|
| Epigenomics | 1 | 2023 | 903 | 0.040 |
Why?
|
| Maximum Tolerated Dose | 1 | 2019 | 892 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2020 | 1866 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2008 | 3036 | 0.040 |
Why?
|
| Radiotherapy | 1 | 2004 | 1533 | 0.040 |
Why?
|
| Headache | 1 | 2005 | 1226 | 0.040 |
Why?
|
| Cell Lineage | 3 | 2016 | 2504 | 0.040 |
Why?
|
| Cartilage | 1 | 2000 | 818 | 0.040 |
Why?
|
| Stem Cells | 1 | 2010 | 3567 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 2006 | 1239 | 0.040 |
Why?
|
| Head and Neck Neoplasms | 1 | 2010 | 2734 | 0.040 |
Why?
|
| Automation, Laboratory | 1 | 2017 | 101 | 0.040 |
Why?
|
| DNA, Complementary | 2 | 1997 | 2050 | 0.040 |
Why?
|
| Major Histocompatibility Complex | 1 | 1999 | 936 | 0.040 |
Why?
|
| Hysterectomy | 1 | 2022 | 927 | 0.030 |
Why?
|
| Benzamides | 1 | 2002 | 1379 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2004 | 1349 | 0.030 |
Why?
|
| Entropy | 1 | 2017 | 209 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 21827 | 0.030 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1997 | 166 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 2025 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2019 | 767 | 0.030 |
Why?
|
| Esophageal Neoplasms | 1 | 2006 | 1583 | 0.030 |
Why?
|
| Hemangiosarcoma | 1 | 2018 | 239 | 0.030 |
Why?
|
| Base Sequence | 1 | 2007 | 12797 | 0.030 |
Why?
|
| Germ Cells | 1 | 2020 | 631 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 1996 | 352 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2022 | 814 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2008 | 6993 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2020 | 2505 | 0.030 |
Why?
|
| Chondrocytes | 1 | 2000 | 804 | 0.030 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2020 | 428 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2023 | 1692 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 1998 | 2645 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2023 | 1990 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2022 | 1660 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2021 | 1301 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2016 | 460 | 0.030 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2014 | 43 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2016 | 376 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 14722 | 0.030 |
Why?
|
| Age of Onset | 1 | 2020 | 3271 | 0.030 |
Why?
|
| Genes, abl | 1 | 2013 | 72 | 0.030 |
Why?
|
| Homozygote | 1 | 2018 | 1785 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2023 | 6489 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2014 | 323 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2014 | 424 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 1997 | 749 | 0.030 |
Why?
|
| Parvoviridae Infections | 1 | 2012 | 35 | 0.030 |
Why?
|
| Cladribine | 1 | 2012 | 34 | 0.030 |
Why?
|
| Retroperitoneal Space | 1 | 2013 | 176 | 0.030 |
Why?
|
| Paraffin Embedding | 1 | 2013 | 299 | 0.030 |
Why?
|
| California | 1 | 2016 | 1402 | 0.030 |
Why?
|
| Roseolovirus Infections | 1 | 2012 | 45 | 0.030 |
Why?
|
| Multiple Myeloma | 1 | 2010 | 5181 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2012 | 25625 | 0.030 |
Why?
|
| Exons | 1 | 1998 | 2437 | 0.030 |
Why?
|
| Dermis | 1 | 2013 | 207 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2012 | 193 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2021 | 2107 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 4933 | 0.020 |
Why?
|
| Chernobyl Nuclear Accident | 1 | 2011 | 15 | 0.020 |
Why?
|
| Salivary Gland Diseases | 1 | 2011 | 37 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2017 | 1534 | 0.020 |
Why?
|
| Proteins | 2 | 2010 | 6103 | 0.020 |
Why?
|
| Ukraine | 1 | 2011 | 111 | 0.020 |
Why?
|
| Neoplasm Metastasis | 2 | 2018 | 4851 | 0.020 |
Why?
|
| Chromosome Banding | 1 | 2010 | 278 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2006 | 4599 | 0.020 |
Why?
|
| Vidarabine | 1 | 2012 | 345 | 0.020 |
Why?
|
| Solubility | 1 | 2012 | 1085 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2022 | 3589 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2006 | 4034 | 0.020 |
Why?
|
| Disease Management | 1 | 2021 | 2459 | 0.020 |
Why?
|
| Mice, Transgenic | 3 | 2013 | 9734 | 0.020 |
Why?
|
| Vincristine | 1 | 2012 | 1039 | 0.020 |
Why?
|
| Hemangioendothelioma | 1 | 2010 | 121 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2018 | 2480 | 0.020 |
Why?
|
| Drosophila | 2 | 1996 | 1491 | 0.020 |
Why?
|
| Frozen Sections | 1 | 2010 | 155 | 0.020 |
Why?
|
| Databases, Factual | 2 | 2016 | 7729 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 15540 | 0.020 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2013 | 664 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 644 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2016 | 2634 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2020 | 1632 | 0.020 |
Why?
|
| Smoking | 1 | 2006 | 8987 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2000 | 226 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2010 | 496 | 0.020 |
Why?
|
| Genome, Bacterial | 1 | 2013 | 760 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2013 | 1465 | 0.020 |
Why?
|
| Skull | 1 | 2013 | 813 | 0.020 |
Why?
|
| Ribonuclease III | 1 | 2010 | 275 | 0.020 |
Why?
|
| Down Syndrome | 1 | 2016 | 880 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2012 | 1663 | 0.020 |
Why?
|
| Gestational Age | 1 | 1996 | 3493 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 2011 | 424 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2008 | 8037 | 0.020 |
Why?
|
| Radiography, Abdominal | 1 | 2011 | 537 | 0.020 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2007 | 113 | 0.020 |
Why?
|
| Thrombopoietin | 1 | 2009 | 225 | 0.020 |
Why?
|
| Prednisone | 1 | 2012 | 1574 | 0.020 |
Why?
|
| Hospitals, General | 1 | 2011 | 749 | 0.020 |
Why?
|
| Mesoderm | 1 | 2010 | 686 | 0.020 |
Why?
|
| Parathyroid Hormone | 1 | 2013 | 1801 | 0.020 |
Why?
|
| Plasma Cells | 1 | 2010 | 591 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2004 | 7279 | 0.020 |
Why?
|
| Cranial Nerve Diseases | 1 | 2007 | 112 | 0.020 |
Why?
|
| Incidence | 1 | 2005 | 20947 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1995 | 4740 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2012 | 2242 | 0.020 |
Why?
|
| Cell Survival | 1 | 1996 | 5882 | 0.020 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2011 | 576 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2011 | 1770 | 0.020 |
Why?
|
| Phylogeny | 1 | 2013 | 2803 | 0.020 |
Why?
|
| Paralysis | 1 | 2007 | 247 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2012 | 1348 | 0.020 |
Why?
|
| Tissue Fixation | 1 | 2006 | 241 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 16689 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2017 | 15519 | 0.020 |
Why?
|
| Graft Survival | 3 | 2000 | 3737 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2010 | 2971 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 5319 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 1996 | 322 | 0.020 |
Why?
|
| Osteoblasts | 1 | 2010 | 1166 | 0.020 |
Why?
|
| Muscle Weakness | 1 | 2007 | 413 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2020 | 19229 | 0.010 |
Why?
|
| Rheumatoid Factor | 1 | 2004 | 188 | 0.010 |
Why?
|
| Gene Expression | 1 | 2017 | 7799 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2009 | 1152 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2017 | 8324 | 0.010 |
Why?
|
| Blood Platelets | 1 | 2014 | 2508 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 3647 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2011 | 3479 | 0.010 |
Why?
|
| Intestines | 1 | 2012 | 1924 | 0.010 |
Why?
|
| Reference Values | 1 | 2010 | 4982 | 0.010 |
Why?
|
| Antibodies, Antinuclear | 1 | 2004 | 326 | 0.010 |
Why?
|
| Aging | 1 | 2021 | 8664 | 0.010 |
Why?
|
| Receptors, Notch | 2 | 1997 | 739 | 0.010 |
Why?
|
| Quality of Life | 1 | 2023 | 12804 | 0.010 |
Why?
|
| Genes, bcl-2 | 1 | 2002 | 122 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2013 | 23403 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2013 | 2541 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2012 | 5524 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 2007 | 1470 | 0.010 |
Why?
|
| Transplantation, Heterologous | 2 | 2000 | 2382 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 25043 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 3772 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 2001 | 331 | 0.010 |
Why?
|
| Nucleosomes | 1 | 2004 | 494 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2006 | 1462 | 0.010 |
Why?
|
| Radiation Chimera | 1 | 2000 | 223 | 0.010 |
Why?
|
| Immunization | 1 | 2004 | 1256 | 0.010 |
Why?
|
| Inflammation | 1 | 2019 | 10638 | 0.010 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2000 | 307 | 0.010 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2000 | 331 | 0.010 |
Why?
|
| Rats | 2 | 2009 | 24260 | 0.010 |
Why?
|
| Leukemia, Myeloid, Accelerated Phase | 1 | 1998 | 7 | 0.010 |
Why?
|
| Growth Plate | 1 | 2000 | 274 | 0.010 |
Why?
|
| Culture Media | 1 | 2001 | 908 | 0.010 |
Why?
|
| Ligands | 2 | 1997 | 3282 | 0.010 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 1999 | 188 | 0.010 |
Why?
|
| Chondroitin Sulfates | 1 | 1998 | 187 | 0.010 |
Why?
|
| Myoglobin | 1 | 1998 | 160 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 1999 | 318 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 2001 | 862 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 2007 | 1848 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1998 | 878 | 0.010 |
Why?
|
| Ankyrin Repeat | 1 | 1997 | 17 | 0.010 |
Why?
|
| Bone Development | 1 | 2000 | 483 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 1999 | 844 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 10943 | 0.010 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 1997 | 121 | 0.010 |
Why?
|
| Myosins | 1 | 1998 | 409 | 0.010 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1996 | 97 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1997 | 402 | 0.010 |
Why?
|
| Diaphragm | 1 | 1998 | 349 | 0.010 |
Why?
|
| Moloney murine leukemia virus | 1 | 1996 | 139 | 0.010 |
Why?
|
| Transplantation, Isogeneic | 1 | 1996 | 257 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1997 | 13815 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2001 | 1877 | 0.010 |
Why?
|
| Feces | 1 | 2001 | 1401 | 0.010 |
Why?
|
| Hyaluronic Acid | 1 | 1998 | 491 | 0.010 |
Why?
|
| Virus Integration | 1 | 1996 | 299 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1998 | 2327 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1996 | 798 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2000 | 13033 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 1994 | 192 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 1997 | 1341 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1997 | 1202 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1997 | 2839 | 0.010 |
Why?
|
| Genes, Insect | 1 | 1994 | 268 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1994 | 547 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 1998 | 1117 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1997 | 2008 | 0.010 |
Why?
|
| Muscles | 1 | 1997 | 1614 | 0.010 |
Why?
|
| DNA | 1 | 2006 | 7301 | 0.010 |
Why?
|
| Chromatin | 1 | 2004 | 2934 | 0.010 |
Why?
|
| Mast Cells | 1 | 2000 | 1544 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1998 | 3689 | 0.010 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1998 | 934 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 4838 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2000 | 2967 | 0.010 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1999 | 1270 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 6364 | 0.010 |
Why?
|
| Kinetics | 1 | 1998 | 6473 | 0.010 |
Why?
|
| Actins | 1 | 1998 | 2121 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1997 | 1676 | 0.010 |
Why?
|
| Transfection | 1 | 1998 | 5892 | 0.010 |
Why?
|
| Melanoma | 1 | 2008 | 5510 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2000 | 8301 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2004 | 14557 | 0.010 |
Why?
|
| Kidney | 1 | 2004 | 7186 | 0.010 |
Why?
|
| Binding Sites | 1 | 1997 | 6114 | 0.000 |
Why?
|
| Apoptosis | 1 | 2004 | 9727 | 0.000 |
Why?
|
| Oncogenes | 1 | 1994 | 1265 | 0.000 |
Why?
|
| Transcriptional Activation | 1 | 1994 | 1783 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1997 | 4161 | 0.000 |
Why?
|
| Drosophila Proteins | 1 | 1996 | 1703 | 0.000 |
Why?
|
| Promoter Regions, Genetic | 1 | 1997 | 5867 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1997 | 5097 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1997 | 18111 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 1997 | 7722 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 2001 | 7181 | 0.000 |
Why?
|
| Cell Line | 1 | 1994 | 15997 | 0.000 |
Why?
|